Literature DB >> 22743757

Polarization toward Th1-type response in active, but not in inactive, lupus inhibits late allergic rhinitis in lupus-prone female NZB×NZWF(1) mice.

Toshiharu Hayashi1, Ayumi Murase.   

Abstract

The association of allergic diseases and disease activity in systemic lupus erythematosus (SLE, lupus) is controversial. The study investigates lupus activity-related differences in the induction of late allergic rhinitis (LAR) in the female NZB×NZW(B/W)F(1) mouse model for lupus. The LAR, which is induced by ovalbumin, was examined during the preactive (before clinical onset) and active (after clinical onset) phases in mice. Induction of LAR was less severe in mice with active lupus in contrast to clinically healthy lupus mice that developed a more severe allergic rhinitis. Inhibition of the development of LAR may be due to reduced eosinophilia and local interleukin-4 secretion during active autoimmune disease. In addition, systemic interferon-γ, but not IL-4, production increased during the active phase, but not the preactive phase. This suggests that the predominating Th1 lineage commitment in mice with active lupus may be responsible for the inhibition of the allergic Th2 response. The present study may shed some light on the controversy of the prevalence of allergic diseases in SLE patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22743757     DOI: 10.1007/s10753-012-9494-x

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

Review 3.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

4.  Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice.

Authors:  Toshiharu Hayashi; Keiko Hasegawa; Chie Adachi
Journal:  Int J Exp Pathol       Date:  2005-10       Impact factor: 1.925

5.  Allergic disorders in systemic lupus erythematosus.

Authors:  J F Sequeira; D Cesic; G Keser; M Bukelica; S Karanagnostis; M A Khamashta; G R Hughes
Journal:  Lupus       Date:  1993-06       Impact factor: 2.911

6.  Promotion of lupus in NZB x NZWF1 mice by plasmids encoding interferon (IFN)-gamma but not by those encoding interleukin (IL)-4.

Authors:  K Hasegawa; T Hayashi; K Maeda
Journal:  J Comp Pathol       Date:  2002-07       Impact factor: 1.311

7.  Serum IgE concentrations, disease activity, and atopic disorders in systemic lupus erythematosus.

Authors:  O Elkayam; R Tamir; A I Pick; A Wysenbeek
Journal:  Allergy       Date:  1995-01       Impact factor: 13.146

Review 8.  Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.

Authors:  Toshiharu Hayashi
Journal:  J Biomed Biotechnol       Date:  2010-08-17

9.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.

Authors:  A N Theofilopoulos; S Koundouris; D H Kono; B R Lawson
Journal:  Arthritis Res       Date:  2001-02-14

10.  Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients.

Authors:  Anna Wozniacka; Anna Sysa-Jedrzejowska; Ewa Robak; Zbigniew Samochocki; Malgorzata Zak-Prelich
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

View more
  2 in total

Review 1.  The pathologic and clinical intersection of atopic and autoimmune disease.

Authors:  Ankoor Shah
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

2.  Mahuang Fuzi Xixin Decoction Attenuates Th1 and Th2 Responses in the Treatment of Ovalbumin-Induced Allergic Inflammation in a Rat Model of Allergic Rhinitis.

Authors:  Mengyue Ren; Qingfa Tang; Feilong Chen; Xuefeng Xing; Yao Huang; Xiaomei Tan
Journal:  J Immunol Res       Date:  2017-07-13       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.